Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
oral
|
| gptkbp:approvalYear |
2013
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:L01XE25
|
| gptkbp:CASNumber |
871700-17-3
|
| gptkbp:chemicalFormula |
C26H23FIN5O4
|
| gptkbp:combines |
gptkb:dabrafenib
|
| gptkbp:contraindication |
pregnancy
|
| gptkbp:developedBy |
GlaxoSmithKline
|
| gptkbp:genericName |
gptkb:trametinib
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mekinist
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
MEK inhibitor
|
| gptkbp:sideEffect |
diarrhea
fatigue hypertension rash |
| gptkbp:usedFor |
gptkb:non-small_cell_lung_cancer
melanoma |
| gptkbp:bfsParent |
gptkb:Novartis
|
| gptkbp:bfsLayer |
4
|